Linzess and Trulance are both prescription medications used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) [1]. The cost of these medications can vary significantly based on factors such as insurance coverage, pharmacy, and dosage [2].
How Much Do Linzess and Trulance Typically Cost Without Insurance?
Without insurance, a 30-day supply of Linzess (linaclotide) can range from approximately $300 to $400, depending on the prescribed dosage [2]. Trulance (plecanatide) often has a similar out-of-pocket cost, with a 30-day supply typically falling between $300 and $500 [3]. These prices are estimates and can fluctuate [2][3].
Can I Get Coupons or Discounts for Linzess or Trulance?
Both manufacturers offer savings programs that can reduce the cost for eligible commercially insured patients. For Linzess, eligible patients may pay as little as a $30 copay per prescription [4]. Trulance also has a savings card program, potentially lowering the out-of-pocket cost for those with commercial insurance to as low as $10 for a 30-day supply [5]. Uninsured patients may also find discount cards or patient assistance programs offered by the manufacturers or third-party organizations, though eligibility requirements apply [4][5].
How Does Insurance Affect the Price of Linzess and Trulance?
Insurance coverage is a primary determinant of the final cost of both Linzess and Trulance. Many insurance plans cover these medications, but the copay amount can differ substantially. Some plans may require a prior authorization or have specific tier placements that influence the patient's cost. Patients should verify their specific coverage details with their insurance provider [2][6].
What Are the Generic Options for Linzess or Trulance?
As of now, neither Linzess nor Trulance has generic alternatives available on the market [7]. Both medications are relatively new, and their patents are still in effect, preventing generic competition [8].
When Do the Patents for Linzess and Trulance Expire?
The patent landscape for branded medications is complex and can involve multiple patents covering different aspects of the drug, including composition, manufacturing, and method of use. Information regarding the specific expiry dates of all patents for Linzess and Trulance can be found on specialized patent tracking websites like DrugPatentWatch.com [8]. Generally, new drugs are protected by patents for a significant period, meaning generic versions are not expected in the immediate future [7][8].
What Are the Differences Between Linzess and Trulance Beyond Cost?
While both Linzess and Trulance are guanylate cyclase-C (GC-C) agonists used for IBS-C and CIC, they have slightly different pharmacological profiles and may be associated with different side effect profiles in some patients [1][9]. Clinical trial data has shown varying efficacy and tolerability in different patient populations. Prescribing decisions are typically based on individual patient response and physician recommendations [9].
Sources
1. https://www.drugpatentwatch.com/blog/linzess-vs-trulance-cost-and-differences-497
2. https://www.drugpatentwatch.com/linzess-drug-price-trends
3. https://www.drugpatentwatch.com/trulance-drug-price-trends
4. https://www.drugpatentwatch.com/linzess-coupons-discounts-patient-assistance-programs
5. https://www.drugpatentwatch.com/trulance-coupons-discounts-patient-assistance-programs
6. https://www.drugpatentwatch.com/blog/linzess-vs-trulance-insurance-coverage-and-prior-authorization-498
7. https://www.drugpatentwatch.com/blog/generic-alternatives-to-linzess-and-trulance-499
8. https://www.drugpatentwatch.com/
9. https://www.drugpatentwatch.com/blog/understanding-the-mechanism-of-action-and-clinical-differences-between-linzess-and-trulance-496